Trial Profile
Open Label, One-arm, 3-month Study of Once-daily Tablet of V3-MOMMO as Immunotherapy of Breast Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs V3-MOMMO (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Sponsors Immunitor
- 06 Jul 2018 New trial record